Several studies have demonstrated that the elevated fasting blood glucose (FBG) may increase the risk of incident dementia in older adults with or without diabetes mellitus (DM). However, similar results are rarely reported in Chinese population.
Objective:
This study aimed to demonstrate the association between FBG and risk of incident cognitive decline in older Chinese adults.
Methods:
We prospectively followed up 1,555 dementia-free participants with baseline FBG measurement in the Shanghai Aging Study.
Results:
We identified 126 incident dementia cases across a mean of 5.2 years. Cumulative dementia incidence in type II DM participants with higher FBG (>6.1 mmol/L) increased most dramatically, second with that of non-DM participants with higher FBG, than that of participants with lower FBG (≤6.1 mmol/L). DM participants had a significant higher risk of incident dementia (adjusted HR 1.51, 95% CI 1.25–1.82) by every 1 mmol/L increment of FBG. Among DM participants, baseline FBG was positively related to the rate of annual decline of MMSE (β= 0.10, p = 0.0018).
Conclusions:
Our results suggest that especially in people with type II DM, effective blood glucose control may help to prevent cognitive impairment in later life.
CranePK, WalkerR, HubbardRA, LiG, NathanDM, ZhengH, HaneuseS, CraftS, MontineTJ, KahnSE, McCormickW, McCurrySM, BowenJD, LarsonEB (2013) Glucose levels and risk of dementia. N Engl J Med369, 540–548.
8.
EuserSM, SattarN, WittemanJCM, BollenELEM, SijbrandsEJG, HofmanA, PerryIJ, BretelerMMB, WestendorpRGJand for PROSPER and the Rotterdam Study (2010) A prospective analysis of elevated fasting glucose levels and cognitive function in older people. Diabetes59, 1601–1607.
9.
XuW, QiuC, WinbladB, FratiglioniL (2007) The effect of borderline diabetes on the risk of dementia and Alzheimer’s disease. Diabetes56, 211–216.
10.
SamarasK, LutgersHL, KochanNA, CrawfordJD, CampbellLV, WenW, SlavinMJ, BauneBT, LipnickiDM, BrodatyH, TrollorJN, SachdevPS (2014) The impact of glucose disorders on cognition and brain volumes in the elderly: The Sydney Memory and Ageing Study. Age36, 977–993.
11.
RouchI, RocheF, DauphinotV, LaurentB, AntérionCT, CelleS, SalmonPK, Jean-Claude, BarthélémyJC (2014) Diabetes, impaired fasting glucose, and cognitive decline in a population of elderly community residents. Aging Clin Exp Res24, 377–383.
12.
YaffeK, FalveyC, HamiltonN, SchwartzAV, SimonsickEM, SatterfieldS, CauleyJA, RosanoC, LaunerLJ, StrotmeyerES, HarrisTB (2012) Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol69, 1170–1175.
13.
Xu WL, von StraussE, QiuCX, WinbladB, FratiglioniL (2009) Uncontrolled diabetes increases the risk of Alzheimer’s disease: A population-based cohort study. Diabetologia52, 1031.
14.
SeetharamanS, AndelR, McEvoyC, AslanAKD, FinkelD, PedersenNL (2014) Blood glucose, diet-based glycemic load and cognitive aging among dementia-free older adults. J Gerontol A Biol Sci Med Sci70, 471–479.
15.
AwadN, GagnonM, MessierC (2004) The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol26, 1044–1080.
16.
YangW, LuJ, WengJ, JiaW, JiL, XiaoJZ, ShanZY, LiuJ, TianHM, JiQH, ZhuDL, GeJP, LinLX, ChenL, GuoXH, ZhaoZG, LiQ, ZhouZG, ShanGL, HeJ (2010) Prevalence of diabetes among men and women in China. N Engl J Med362, 1090–1101.
17.
FeiM, Yan PingZ, Ru JuanM, Ning NingL, LinG (2013) Risk factors for dementia with type 2 diabetes mellitus among elderly people in China. Age Ageing42, 398–400.
18.
GaoY, XiaoY, MiaoR, ZhaoJ, CuiM, HuangG, FeiM (2016) The prevalence of mild cognitive impairment with type 2 diabetes mellitus among elderly people in China: A cross-sectional study. Arch Gerontol Geriatr62, 138–142.
19.
JiaJ, ZhouA, WeiC, JiaX, WangF, LiF, WuX, VincentM, SergeG, TangM, ChuL (2014) The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese. Alzheimers Dement10, 439–447.
20.
HilalS1, IkramMK, SainiM, TanCS, CatindigJA, DongYH, LimLB, TingEY, KooEH, CheungCY, QiuA, WongTY, ChenCL, VenketasubramanianN (2013) Prevalence of cognitive impairment in Chinese: Epidemiology of dementia in Singapore study. J Neurol Neurosurg Psychiatry84, 686–692.
21.
WooJ, HoS C, LauS, LauJ, YuenYK (1994) Prevalence of cognitive impairment and associated factors among elderly Hong Kong Chinese aged 70 years and over. Neuroepidemiology13, 50–58.
22.
Ho RC, NitiM, Yap KB, Kua EH, NgT P (2008) Metabolic syndrome and cognitive decline in Chinese older adults: Results from the Singapore longitudinal ageing studies. Am J Geriatr Psychiatry16, 519–522.
23.
Ho SC, WooJ, ShamA, Chan SG, Yu AL (2001) A 3-year follow-up study of social, lifestyle and health predictors of cognitive impairment in a Chinese older cohort. Int J Epidemiol30, 1389–1396.
24.
DingD, ZhaoQ, GuoQ, MengH, WangB, YuP, LuoJ, ZhouY, YuL, ZhengL, ChuS, MortimerJA, BorensteinAR, HongZ (2014) The Shanghai Aging Study: Study design, baseline characteristics, and prevalence of dementia. Neuroepidemiology43, 114–122.
25.
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet363, 157–163.
26.
Aubree-LecatA, HervagaultC, DelacourA, BeaudeP, BourdillonC, RemyM (1989) Direct electrochemical determination of glucose oxidase in biological samples. Anal Biochem178, 427–430.
27.
World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. World Health Organization, Geneva, Switzerland.
28.
ZhangMY, KatzmanR, SalmonD, JinH, CaiGJ, WangZY, QuGY, GrantI, YuE (1990) The prevalence of dementia and Alzheimer’s disease in Shanghai, China: Impact of age, gender, and education. Ann Neurol27, 428–437.
29.
DingD, ZhaoQ, GuoQ, MengH, WangB, LuoJ, MortimerJA, BorensteinAR, HongZ (2015) Prevalence of mild cognitive impairment in an urban community in China: A cross-sectional analysis of the Shanghai Aging Study. Alzheimers Dement11, 3009.e2.
30.
ZhangJ, NorvilitisJM (2002) Measuring Chinese psychological well-being with Western developed instruments. J Pers Assess79, 492–511.
31.
MorrisJC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology43, 2412–2414.
32.
LimWS, ChongMS, SahadevanS (2007) Utility of the clinical dementia rating in Asian populations. Clin Med Res5, 61–70.
33.
LawtonMP, BrodyEM (1969) Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist9, 179–186.
34.
American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, DC.
35.
SmirnovDA, MorleyM, ShinE, SpielmanRS, CheungVG (2009) Genetic analysis of radiation-induced changes in human gene expression. Nature459, 587–591.
36.
KatzmanR, BrownT, ThalLJ, FuldPA, AronsonM, ButtersN, KlauberMR, WiederholtW, PayM, XiongRB (1998) Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer’s disease. Ann Neurol24, 384–389.
37.
Van OijenM, OkerekeOI, KangJH, PollakMN, HuFB, HankinsonSE, GrodsteinF (2008) Fasting insulin levels and cognitive decline in older women without diabetes. Neuroepidemiology30, 174–179.
38.
PeilaR, RodriguezBL, LaunerLJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes51, 1256–1262.
39.
van HartenB, de LeeuwFE, WeinsteinHC, ScheltensP, BiesselsGJ (2006) Brain imaging in patients with diabetes: A systematic review. Diabetes Care29, 2539–2548.
40.
KatzmanR, Zhang MY, Chen PJ, GuN, JiangS, SaitohT, ChenX, KlauberM, TomasRG, LiuWT, YuESH (1997) Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia. Neurology49, 779–785.
41.
HongCJ, LiuTY, LiuHC, WangSJ, FuhJL, ChiCW, LeeKY, SimCB (1996) Epsilon 4 allele of apolipoprotein E increases risk of Alzheimer’s disease in a Chinese population. Neurology46, 1749–1751.
42.
YangJ, FengG, ZhangJ, HuiZ, BreenG, St ClairD, HeL (2001) Is ApoE gene a risk factor for vascular dementia in Han Chinese?Int J Mol Med7, 217–219.
43.
HuP, QingYH, JingCX, LuL, HuB, DuPF (2011) Does the geographical gradient of ApoE4 allele exist in China? A systemic comparison among multiple Chinese populations. Mol Biol Rep38, 489–494.
44.
LiangS, PanM, GengHH, ChenH, GuLQ, QinXT, QianJJ, ZhuJH, LiuCF (2009) Apolipoprotein E polymorphism in normal Han Chinese population: Frequency and effect on lipid parameters. Mol Biol Rep36, 1251–1256.
45.
KatzmanR, ZhangMY, ChenPJ, GuN, JiangS, SaitohT, ChenX, KlauberM, ThomasRG, LiuWT, YuESH (1997) Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia. Neurology49, 779–785.
46.
JunG, NajA, BeechamGW, WangL, BurosJ, GallinsP, BuxbaumJ (2010) Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer’s disease risk loci and reveals interactions with APOE genotypes. Arch Neurol67, 1473–1484.
47.
WhitmerRA, SidneyS, SelbyJ, JohnstonSC, YaffeK (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology64, 277–281.
48.
YaffeK, KanayaA, LindquistK, SimonsickEM, HarrisT, ShorrRI, TylavskyFA, NewmanAB (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA292, 2237–2242.
49.
KernanWN, InzucchiSE, ViscoliCM, BrassLM, BravataDM, HorwitzRI (2002) Insulin resistance and risk for stroke. Neurology59, 809–815.
FarrisW, MansourianS, ChangY, LindsleyL, EckmanEA, FroschMP, EckmanCB, TanziRE, SelkoeDJ, GuénetteS (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain. Proc Natl Acad Sci U S A100, 4162–4167.
55.
KalmijnS, LaunerLJ, LindemansJ, BotsML, HofmanA, Breteler MMB (1999) Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam Study. Am J Epidemiol150, 283–289.
56.
SchaferJH, GlassTA, BollaKI, MintzM, JedlickaAE, SchwartzBS (2005) Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc53, 381–388.
